M01-RR05096/RR/NCRR NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2004	1
2005	2
2006	3
2007	3
2024	0

1

Lowering blood pressure with beta-blockers in combination with other renin-angiotensin system blockers in patients with hypertension and type 2 diabetes: results from the GEMINI Trial.

Wright JT Jr, Bakris GL, Bell DS, Fonseca V, Katholi RE, McGill JB, Messerli FH, Phillips RA, Raskin P, Holdbrook FK, Lukas MA, Iyengar M. Wright JT Jr, et al. J Clin Hypertens (Greenwich). 2007 Nov;9(11):842-9. doi: 10.1111/j.1524-6175.2007.07251.x. J Clin Hypertens (Greenwich). 2007. PMID: 17978591 Free PMC article. Clinical Trial.

2

Effects of verbal cue on bolus flow during swallowing.

Daniels SK, Schroeder MF, DeGeorge PC, Corey DM, Rosenbek JC. Daniels SK, et al. Am J Speech Lang Pathol. 2007 May;16(2):140-7. doi: 10.1044/1058-0360(2007/018). Am J Speech Lang Pathol. 2007. PMID: 17456892

3

Depo-medroxyprogesterone in women on antiretroviral therapy: effective contraception and lack of clinically significant interactions.

Cohn SE, Park JG, Watts DH, Stek A, Hitti J, Clax PA, Yu S, Lertora JJ; ACTG A5093 Protocol Team. Cohn SE, et al. Clin Pharmacol Ther. 2007 Feb;81(2):222-7. doi: 10.1038/sj.clpt.6100040. Epub 2006 Dec 27. Clin Pharmacol Ther. 2007. PMID: 17192768 Clinical Trial.

4

Dysphagia in stroke: Development of a standard method to examine swallowing recovery.

Daniels SK, Schroeder MF, McClain M, Corey DM, Rosenbek JC, Foundas AL. Daniels SK, et al. J Rehabil Res Dev. 2006 May-Jun;43(3):347-56. doi: 10.1682/jrrd.2005.01.0024. J Rehabil Res Dev. 2006. PMID: 17041820 Free article.

5

The clinical pharmacokinetics of rifampin and ethambutol in HIV-infected persons with tuberculosis.

Perlman DC, Segal Y, Rosenkranz S, Rainey PM, Remmel RP, Salomon N, Hafner R, Peloquin CA; AIDS Clinical Trials Group 309 Team. Perlman DC, et al. Clin Infect Dis. 2005 Dec 1;41(11):1638-47. doi: 10.1086/498024. Epub 2005 Oct 28. Clin Infect Dis. 2005. PMID: 16267738 Clinical Trial.

6

Glucose metabolism, lipid, and body fat changes in antiretroviral-naive subjects randomized to nelfinavir or efavirenz plus dual nucleosides.

Dubé MP, Parker RA, Tebas P, Grinspoon SK, Zackin RA, Robbins GK, Roubenoff R, Shafer RW, Wininger DA, Meyer WA 3rd, Snyder SW, Mulligan K. Dubé MP, et al. AIDS. 2005 Nov 4;19(16):1807-18. doi: 10.1097/01.aids.0000183629.20041.bb. AIDS. 2005. PMID: 16227788 Clinical Trial.

7

Effect of the novel direct factor Xa inhibitor DX-9065a on thrombin generation and inhibition among patients with stable atherosclerotic coronary artery disease.

Becker RC, Alexander JH, Dyke C, Huang Y, Saint-Jacques H, Hasselblad V, Harrington RA, Bovill EG; XaNADU-1B Investigators. Becker RC, et al. Thromb Res. 2006;117(4):439-46. doi: 10.1016/j.thromres.2005.03.017. Thromb Res. 2006. PMID: 15882894 Clinical Trial.

8

The clinical pharmacokinetics of pyrazinamide in HIV-infected persons with tuberculosis.

Perlman DC, Segal Y, Rosenkranz S, Rainey PM, Peloquin CA, Remmel RP, Chirgwin K, Salomon N, Hafner R; ACTG 309 Team. Perlman DC, et al. Clin Infect Dis. 2004 Feb 15;38(4):556-64. doi: 10.1086/381096. Epub 2004 Jan 28. Clin Infect Dis. 2004. PMID: 14765350

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

8 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year